Emyria Limited (ASX:EMD) has disclosed that two directors exercised vested performance rights into fully paid ordinary shares on 16 November 2026, with Mr Greg Hutchinson converting 9,500,000 performance rights and Dr Michael Winlo converting 1,000,000 performance rights, both at nil consideration under the company's Employee Incentive Plan.

Key Points

  • Mr Greg Hutchinson exercised 9,500,000 vested performance rights (expiring 28 May 2031) into 9,500,000 fully paid ordinary shares on 16 November 2026 at nil consideration.
  • Following the change, Hutchinson's Gregory Ross Hutchinson <G & L A/C> holding increased to 52,154,762 fully paid ordinary shares, with 16,080,000 performance rights (expiring 28 May 2031) remaining.
  • Dr Michael Winlo exercised 1,000,000 vested performance rights (expiring 28 May 2031) into 1,000,000 fully paid ordinary shares on 16 November 2026 at nil consideration.
  • Following the change, Winlo's direct holding of fully paid ordinary shares increased to 2,324,230, with 3,500,000 performance rights (expiring 28 May 2031) remaining.
  • Neither transaction was conducted during a closed period requiring prior written clearance.

Greg Hutchinson Performance Rights Exercise Details

According to the filing, Mr Greg Hutchinson held 42,654,762 fully paid ordinary shares in the Gregory Ross Hutchinson <G & L A/C> account prior to the change on 16 November 2026. He acquired 9,500,000 fully paid ordinary shares through the exercise of 9,500,000 vested performance rights expiring 28 May 2031, with nil consideration paid. The nature of the change was described as the exercise of vested performance rights pursuant to the terms and conditions of the company's Employee Incentive Plan. His remaining securities include 2,500,000 performance rights expiring 28 March 2028, various unlisted options, and 16,080,000 performance rights expiring 28 May 2031.

Michael Winlo Performance Rights Exercise Details

Dr Michael Winlo held 1,324,230 fully paid ordinary shares directly prior to the 16 November 2026 change, in addition to various unlisted options and 4,500,000 performance rights expiring 28 May 2031. He acquired 1,000,000 fully paid ordinary shares through the exercise of 1,000,000 vested performance rights expiring 28 May 2031, at nil consideration, pursuant to the terms and conditions of the company's Employee Incentive Plan. Following the transaction, his direct holding of fully paid ordinary shares stands at 2,324,230, with 3,500,000 performance rights expiring 28 May 2031 remaining. The filing also noted that 32,148 unlisted options exercisable at $0.12 expired on 5 October 2026.

Securities Holdings After Change

Following both transactions, Mr Hutchinson's account retains 5,000,000 options exercisable at $0.051 each on or before 28 March 2028, 3,000,000 unlisted options exercisable at $0.10 each on or before 7 May 2027, 2,527,777 unlisted options exercisable at $0.05 each on or before 1 March 2027, and 10,663,691 unlisted options exercisable at $0.05 each expiring 22 March 2027. Dr Winlo retains 200,000 unlisted options exercisable at $0.10 each on or before 7 May 2027, 2,000,000 unlisted options exercisable at $0.051 each on or before 28 March 2028, and 3,000,000 unlisted options exercisable at $0.296 each on or before 23 November 2026, held via the Winlo A/C.